Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease

BACKGROUND: Tricyclic antidepressants (TCAs) have efficacy in treating irritable bowel syndrome (IBS). Some clinicians use TCAs to treat residual symptoms in inflammatory bowel disease (IBD) patients already on decisive IBD therapy or with quiescent inflammation, although this strategy has not been...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Iskandar, Heba N., Cassell, Benjamin, Kanuri, Navya, Gyawali, C. Prakash, Gutierrez, Alexandra, Dassopoulos, Themistocles, Ciorba, Matthew A., Sayuk, Gregory S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111227/
https://ncbi.nlm.nih.gov/pubmed/24406434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000000049
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky